Form 4 for TMDX TransMedics Group, Inc.
Accepted 2025-01-10 00:00:00 ET · period of report 2025-01-07 · accession 0000950170-25-004192 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-01-10 | 2025-01-07 | TMDX | Khayal Tamer I | Chief Commercial Off | S - Sale+OE | $80.05 | -1,083 | 20.8K | -5% | -$86.7K |
| DT | 2025-01-10 | 2025-01-07 | TMDX | Khayal Tamer I | Chief Commercial Off | M - OptEx | $13.28 | +1,083 | 21.9K | +5% | +$14.4K |
| DT | 2025-01-10 | 2025-01-07 | TMDX | Khayal Tamer I | Chief Commercial Off | M - OptEx | $0.00 | -1,083 | 15.2K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-07 | S | D | 1,083 | $80.05 | 20,843 | D | — | — | (F2) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $80.00 to $80.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 2 | Common | Common Stock | 2025-01-07 | M | A | 1,083 | $13.28 | 21,926 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-01-07 | M | D | 1,083 | $0.00 | 15,167 | D | $13.28 · — to 2032-02-22 | 1,083 Common Stock | (F3) The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026. |